Targeting the Hippo Pathway in Cutaneous Melanoma

被引：1

作者：

Kazimierczak, Urszula ^{[1
]}

Przybyla, Anna ^{[1
]}

Smielowska, Marianna ^{[2
]}

Kolenda, Tomasz ^{[3
,4
]}

Mackiewicz, Andrzej ^{[1
,5
]}

机构：

[1] Poznan Univ Med Sci, Dept Canc Immunol, Rokietnicka St 8, PL-61806 Poznan, Poland

[2] Polish Acad Sci, Inst Bioorgan Chem, Dept Genome Engn, Z Noskowskiego 12-14, PL-61704 Poznan, Poland

[3] Greater Poland Canc Ctr, Lab Canc Genet, Garbary 15, PL-61866 Poznan, Poland

[4] Greater Poland Canc Ctr, Res & Implementat Unit, Garbary 15, PL-61866 Poznan, Poland

[5] Greater Poland Canc Ctr, Dept Canc Diagnost & Immunol, Garbary St 15, PL-61866 Poznan, Poland

来源：

CELLS | 2024年 / 13卷 / 12期

关键词：

cutaneous melanoma; Hippo pathway; therapeutic targets; BRAF INHIBITOR RESISTANCE; ORGAN SIZE CONTROL; SIGNALING-PATHWAY; CELL-PROLIFERATION; TUMOR-SUPPRESSOR; NUCLEAR TRANSLOCATION; CONTACT INHIBITION; CASPASE CLEAVAGE; YAP; KINASE;

D O I：

10.3390/cells13121062

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Melanoma is the most aggressive form of skin cancer. In the advanced stage of development, it is resistant to currently available therapeutic modalities. Increased invasiveness and metastatic potential depend on several proteins involved in various signal transduction pathways. Hippo signaling plays a vital role in malignant transformation. Dysfunctions of the Hippo pathway initiate the expression of tumor growth factors and are associated with tumor growth and metastasis formation. This review summarizes the recent achievements in studying the role of the Hippo pathway in melanoma pathogenesis and points to the potential specific targets for anti-melanoma therapy.

引用

页数：15

共 50 条

[31] Targeting the Hippo pathway for candidate cancer therapy.
Hong, Wanjin
MOLECULAR CANCER RESEARCH, 2020, 18 (08) : 16 - 17
[32] Targeting the RAS pathway in melanoma
Ji, Zhenyu
Flaherty, Keith T.
Tsao, Hensin
TRENDS IN MOLECULAR MEDICINE, 2012, 18 (01) : 27 - 35
[33] Targeting Hippo signaling pathway by phytochemicals in cancer therapy
Moloudizargari, Milad
Asghari, Mohammad Hossein
Nabavi, Seyed Fazel
Gulei, Diana
Berindan-Neagoe, Ioana
Bishayee, Anupam
Nabavi, Seyed Mohammad
SEMINARS IN CANCER BIOLOGY, 2022, 80 : 183 - 194
[34] Characterization of the Hippo Pathway in Melanoma: Focus on the effectors YAP and TAZ
Nallet-Staub, F.
Gilbert, C.
Dodier, S.
Bataille, V.
Sudol, M.
Li, L.
Herlyn, M.
Mauviel, A.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2012, 132 : S128 - S128
[35] Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer Therapy
Juan, Wen Chun
Hong, Wanjin
GENES, 2016, 7 (09):
[36] Targeting the Hippo Pathway in Prostate Cancer: What's New?
Coffey, Kelly
CANCERS, 2021, 13 (04) : 1 - 17
[37] Targeting the Hippo Pathway as Anti-Migration Therapy in Glioblastoma
Barrette, Anne Marie
Bouras, Alexandros
Nudelman, German
Zaslavsky, Elena
Hadjipanayis, Constantinos
Birtwistle, Marc
Tsankova, Nadejda
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2020, 79 (06): : 658 - 658
[38] Targeting Hippo Pathway Diminishes Disease Signaling in Scleroderma Skin
Plazyo, Olesya
Wasikowski, Rachael
Gharaee-Kermani, Mehrnaz
Tsou, Eliza Pei-Suen
Tsoi, Lam
Billi, Allison
Kahlenberg, J. Michelle
Varga, John
Gudjonsson, Johann
Khanna, Dinesh
ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 3742 - 3743
[39] Targeting Hippo pathway diminishes disease signaling in scleroderma skin
Plazyo, Olesya
Wasikowski, Rachael
Gharaee-Kermani, Mehrnaz
Tsou, Eliza Pei-Suen
Tsoi, Lam
Billi, Allison
Kahlenberg, J.
Varga, John
Khanna, Dinesh
Gudjonsson, Johann
JOURNAL OF IMMUNOLOGY, 2024, 212 (01):
[40] Verteporfin suppresses osteosarcoma progression by targeting the Hippo signaling pathway
Yang, Xianliang
Xu, Youjia
Jiang, Chao
Ma, Ziping
Jin, Linguang
ONCOLOGY LETTERS, 2021, 22 (04)

← 1 2 3 4 5 →